Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
Clinical trial NCT05310084 · COMPLETED
Trial details
- NCT number
- NCT05310084
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-20
- Primary completion
- 2022-10-05
- Enrollment
- 1134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.